Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01691781 · ClinicalTrials.gov registry record · NA
The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01691781 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 41 participants.
The verdict
NCT01691781, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study will evaluate whether commonly used blood pressure medications called "ACE inhibitors" can lower parathyroid hormone.
Interventions
- DRUG Lisinopril
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01691781
The ClinicalTrials.gov registry entry for NCT01691781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lisinopril is the first listed.
NCT01691781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01691781 about?
NCT01691781 is a clinical study titled "The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study". This study will evaluate whether commonly used blood pressure medications called "ACE inhibitors" can lower parathyroid hormone.
What is the current status of trial NCT01691781?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-10. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01691781?
The interventions under investigation include: Lisinopril (DRUG).
Who is sponsoring clinical trial NCT01691781?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.